Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

IVIg-induced plasmablasts in patients with Guillain-Barré syndrome.

Brem MD, Jacobs BC, van Rijs W, Fokkink WJR, Tio-Gillen AP, Walgaard C, van Doorn PA, IJspeert H, van der Burg M, Huizinga R.

Ann Clin Transl Neurol. 2018 Nov 27;6(1):129-143. doi: 10.1002/acn3.687. eCollection 2019 Jan.

2.

Mycoplasma Pneumoniae and Antibodies against Galactocerebroside in a 9-Year-Old Boy with Encephalitis.

Smolders J, Jacobs BC, Tio-Gillen AP, Nijhuis F, Verrips A.

Neuropediatrics. 2019 Feb;50(1):54-56. doi: 10.1055/s-0038-1676054. Epub 2018 Nov 26.

PMID:
30477031
3.

Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae.

Meyer Sauteur PM, de Bruijn ACJM, Graça C, Tio-Gillen AP, Estevão SC, Hoogenboezem T, Hendriks RW, Berger C, Jacobs BC, van Rossum AMC, Huizinga R, Unger WWJ.

Infect Immun. 2019 Jan 24;87(2). pii: e00663-18. doi: 10.1128/IAI.00663-18. Print 2019 Feb.

PMID:
30396892
4.

Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.

Taams NE, Notermans NC, Fokkink WR, Tio-Gillen AP, Huizinga R, Schreurs MWJ, Jacobs BC.

J Peripher Nerv Syst. 2018 Dec;23(4):227-234. doi: 10.1111/jns.12285. Epub 2018 Sep 12.

PMID:
30101437
5.

Intrathecal antibody responses to GalC in Guillain-Barré syndrome triggered by Mycoplasma pneumoniae.

Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, Drenthen J, Unger WWJ, Jacobs E, van Rossum AMC, Jacobs BC.

J Neuroimmunol. 2018 Jan 15;314:13-16. doi: 10.1016/j.jneuroim.2017.11.011. Epub 2017 Nov 16.

PMID:
29301655
6.

Antibody responses to GalC in severe and complicated childhood Guillain-Barré syndrome.

Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, de Wit MY, Unger WWJ, Berger C, van Rossum AMC, Jacobs BC.

J Peripher Nerv Syst. 2018 Mar;23(1):67-69. doi: 10.1111/jns.12243. No abstract available.

7.

Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré Syndrome.

Fokkink WR, Walgaard C, Kuitwaard K, Tio-Gillen AP, van Doorn PA, Jacobs BC.

JAMA Neurol. 2017 Feb 1;74(2):189-196. doi: 10.1001/jamaneurol.2016.4480.

PMID:
28027337
8.

Mycoplasma pneumoniae triggering the Guillain-Barré syndrome: A case-control study.

Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, Roodbol J, Hoogenboezem T, Jacobs E, van Rijn M, van der Eijk AA, Vink C, de Wit MC, van Rossum AM, Jacobs BC.

Ann Neurol. 2016 Oct;80(4):566-80. doi: 10.1002/ana.24755. Epub 2016 Aug 26.

PMID:
27490360
9.

Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS.

Fokkink WJ, Haarman AE, Tio-Gillen AP, van Rijs W, Huizinga R, van Doorn PA, Jacobs BC.

Ann Clin Transl Neurol. 2016 May 17;3(7):547-51. doi: 10.1002/acn3.307. eCollection 2016 Jul. Erratum in: Ann Clin Transl Neurol. 2017 Jan 09;4(1):71.

10.

Intrathecal Anti-GalC Antibodies in Bickerstaff Brain Stem Encephalitis.

Sauteur PM, Hackenberg A, Tio-Gillen AP, van Rossum AM, Berger C, Jacobs BC.

Neuropediatrics. 2015 Dec;46(6):428-30. doi: 10.1055/s-0035-1566730. Epub 2015 Nov 4. No abstract available.

PMID:
26535876
11.

Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome.

Huizinga R, van den Berg B, van Rijs W, Tio-Gillen AP, Fokkink WJ, Bakker-Jonges LE, Geleijns K, Samsom JN, van Doorn PA, Laman JD, Jacobs BC.

Ann Neurol. 2015 Sep;78(3):343-54. doi: 10.1002/ana.24442. Epub 2015 Jun 30.

PMID:
26017721
12.

Association of IgM monoclonal gammopathy with progressive muscular atrophy and multifocal motor neuropathy: a case-control study.

Vlam L, Piepers S, Sutedja NA, Jacobs BC, Tio-Gillen AP, Stam M, Franssen H, Veldink JH, Cats EA, Notermans NC, Bloem AC, Wadman RI, van der Pol WL, van den Berg LH.

J Neurol. 2015 Mar;262(3):666-73. doi: 10.1007/s00415-014-7612-4. Epub 2015 Jan 1.

PMID:
25549972
13.

Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the Guillain-Barré syndrome.

Cats EA, van der Pol WL, Tio-Gillen AP, Diekstra FP, van den Berg LH, Jacobs BC.

J Neurol Neurosurg Psychiatry. 2015 May;86(5):502-4. doi: 10.1136/jnnp-2014-308118. Epub 2014 Aug 25.

PMID:
25157033
14.

IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.

Fokkink WJ, Selman MH, Dortland JR, Durmuş B, Kuitwaard K, Huizinga R, van Rijs W, Tio-Gillen AP, van Doorn PA, Deelder AM, Wuhrer M, Jacobs BC.

J Proteome Res. 2014 Mar 7;13(3):1722-30. doi: 10.1021/pr401213z. Epub 2014 Feb 17.

PMID:
24533874
15.

Prevalence, specificity and functionality of anti-ganglioside antibodies in neuropathy associated with IgM monoclonal gammopathy.

Stork AC, Jacobs BC, Tio-Gillen AP, Eurelings M, Jansen MD, van den Berg LH, Notermans NC, van der Pol WL.

J Neuroimmunol. 2014 Mar 15;268(1-2):89-94. doi: 10.1016/j.jneuroim.2014.01.012. Epub 2014 Jan 29.

PMID:
24529728
16.

Guillain-Barré syndrome associated with preceding hepatitis E virus infection.

van den Berg B, van der Eijk AA, Pas SD, Hunter JG, Madden RG, Tio-Gillen AP, Dalton HR, Jacobs BC.

Neurology. 2014 Feb 11;82(6):491-7. doi: 10.1212/WNL.0000000000000111. Epub 2014 Jan 10.

PMID:
24415572
17.

Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy.

Kuitwaard K, van Doorn PA, Vermeulen M, van den Berg LH, Brusse E, van der Kooi AJ, van der Pol WL, van Schaik IN, Notermans N, Tio-Gillen AP, van Rijs W, van Gelder T, Jacobs BC.

J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):859-61. doi: 10.1136/jnnp-2012-304670. Epub 2013 Mar 28.

PMID:
23538070
18.

Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.

Islam Z, Gilbert M, Mohammad QD, Klaij K, Li J, van Rijs W, Tio-Gillen AP, Talukder KA, Willison HJ, van Belkum A, Endtz HP, Jacobs BC.

PLoS One. 2012;7(8):e43976. doi: 10.1371/journal.pone.0043976. Epub 2012 Aug 27.

19.

Detection of antibodies in neuropathy patients by synthetic GM1 mimics.

Pukin AV, Jacobs BC, Tio-Gillen AP, Gilbert M, Endtz HP, van Belkum A, Visser GM, Zuilhof H.

Glycobiology. 2011 Dec;21(12):1642-50. doi: 10.1093/glycob/cwr093. Epub 2011 Jul 27.

PMID:
21798866
20.

Screening for antecedent Campylobacter jejuni infections and anti-ganglioside antibodies in idiopathic neuralgic amyotrophy.

van Eijk JJ, van Alfen N, Tio-Gillen AP, Maas M, Herbrink P, Portier RP, van Doorn PA, van Engelen BG, Jacobs BC.

J Peripher Nerv Syst. 2011 Jun;16(2):153-6. doi: 10.1111/j.1529-8027.2011.00339.x. No abstract available.

PMID:
21692917
21.

Selective depletion of neuropathy-related antibodies from human serum by monolithic affinity columns containing ganglioside mimics.

Tetala KK, Heikema AP, Pukin AV, Weijers CA, Tio-Gillen AP, Gilbert M, Endtz HP, van Belkum A, Zuilhof H, Visser GM, Jacobs BC, van Beek TA.

J Med Chem. 2011 May 26;54(10):3500-5. doi: 10.1021/jm101594s. Epub 2011 Apr 22.

PMID:
21488704
22.

Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features.

Cats EA, Jacobs BC, Yuki N, Tio-Gillen AP, Piepers S, Franssen H, van Asseldonk JT, van den Berg LH, van der Pol WL.

Neurology. 2010 Nov 30;75(22):1961-7. doi: 10.1212/WNL.0b013e3181ff94c2. Epub 2010 Oct 20.

PMID:
20962291
23.

Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.

Kuitwaard K, de Gelder J, Tio-Gillen AP, Hop WC, van Gelder T, van Toorenenbergen AW, van Doorn PA, Jacobs BC.

Ann Neurol. 2009 Nov;66(5):597-603. doi: 10.1002/ana.21737.

PMID:
19938102
24.

Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.

Kuijf ML, Eurelings M, Tio-Gillen AP, van Doorn PA, van den Berg LH, Hooijkaas H, Stork J, Notermans NC, Jacobs BC.

Neurology. 2009 Sep 1;73(9):688-95. doi: 10.1212/WNL.0b013e3181b59a80.

PMID:
19720975
25.

Effect of glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome.

Dekker MJ, van den Akker EL, Koper JW, Manenschijn L, Geleijns K, Ruts L, van Rijs W, Tio-Gillen AP, van Doorn PA, Lamberts SW, Jacobs BC.

J Peripher Nerv Syst. 2009 Jun;14(2):75-83. doi: 10.1111/j.1529-8027.2009.00216.x.

PMID:
19691529
26.

STD-NMR used to elucidate the fine binding specificity of pathogenic anti-ganglioside antibodies directly in patient serum.

Houliston RS, Jacobs BC, Tio-Gillen AP, Verschuuren JJ, Khieu NH, Gilbert M, Jarrell HC.

Biochemistry. 2009 Jan 20;48(2):220-2. doi: 10.1021/bi802100u.

PMID:
19105626
27.

GM3, GM2 and GM1 mimics designed for biosensing: chemoenzymatic synthesis, target affinities and 900 MHz NMR analysis.

Pukin AV, Weijers CA, van Lagen B, Wechselberger R, Sun B, Gilbert M, Karwaski MF, Florack DE, Jacobs BC, Tio-Gillen AP, van Belkum A, Endtz HP, Visser GM, Zuilhof H.

Carbohydr Res. 2008 Mar 17;343(4):636-50. doi: 10.1016/j.carres.2008.01.007. Epub 2008 Jan 16.

PMID:
18255051
28.

Origin of ganglioside complex antibodies in Guillain-Barré syndrome.

Kuijf ML, Godschalk PC, Gilbert M, Endtz HP, Tio-Gillen AP, Ang CW, van Doorn PA, Jacobs BC.

J Neuroimmunol. 2007 Aug;188(1-2):69-73. Epub 2007 Jun 29.

PMID:
17604126
29.

Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome.

Geleijns K, Roos A, Houwing-Duistermaat JJ, van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA, Jacobs BC.

J Immunol. 2006 Sep 15;177(6):4211-7.

30.

Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.

Godschalk PC, Gilbert M, Jacobs BC, Kramers T, Tio-Gillen AP, Ang CW, Van den Braak N, Li J, Verbrugh HA, Van Belkum A, Endtz HP.

Microbes Infect. 2006 Jan;8(1):248-53. Epub 2005 Sep 13.

PMID:
16213180
31.

Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.

Kuijf ML, van Doorn PA, Tio-Gillen AP, Geleijns K, Ang CW, Hooijkaas H, Hop WC, Jacobs BC.

J Neurol Sci. 2005 Dec 15;239(1):37-44. Epub 2005 Sep 8.

PMID:
16154154
32.

Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome.

Geleijns K, Laman JD, van Rijs W, Tio-Gillen AP, Hintzen RQ, van Doorn PA, Jacobs BC.

J Neuroimmunol. 2005 Apr;161(1-2):183-9.

PMID:
15748958
33.

Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.

Geleijns K, Jacobs BC, Van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA.

J Neuroimmunol. 2004 May;150(1-2):132-8.

PMID:
15081257
34.

Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barré syndrome.

Ang CW, Tio-Gillen AP, Groen J, Herbrink P, Jacobs BC, Van Koningsveld R, Osterhaus AD, Van der Meché FG, van Doorn PA.

J Neuroimmunol. 2002 Sep;130(1-2):179-83.

PMID:
12225900
35.

Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.

Ang CW, Laman JD, Willison HJ, Wagner ER, Endtz HP, De Klerk MA, Tio-Gillen AP, Van den Braak N, Jacobs BC, Van Doorn PA.

Infect Immun. 2002 Mar;70(3):1202-8.

36.

Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome.

Jacobs BC, van Doorn PA, Groeneveld JH, Tio-Gillen AP, van der Meché FG.

J Neurol Neurosurg Psychiatry. 1997 Jun;62(6):641-3.

37.

Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.

Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meché FG.

Ann Neurol. 1996 Aug;40(2):181-7.

PMID:
8773599
38.

The influence of T cells on homogeneous immunoglobulins in sera of athymic nude mice during aging.

van den Akker TW, Tio-Gillen AP, Solleveld HA, Benner R, Radl J.

Scand J Immunol. 1988 Sep;28(3):359-65.

PMID:
3143151
39.

The influence of H-2 genetic factors on the development of benign monoclonal gammopathy in ageing H-2 congenic C57BL and BALB mice.

van den Akker TW, Tio-Gillen AP, Benner R, Zurcher C, Radl J.

Immunology. 1987 Aug;61(4):403-8.

Supplemental Content

Loading ...
Support Center